PharmaRadar360

PharmaRadar360

🌍·2d agoRegulatory

ANMAT emitió una Carta de Advertencia a UGAL FARMACÉUTICA S.A. por incumplimientos a las Buenas Prácticas de Fabricación

Publisher

A
ANMAT Noticias

Argentina

This page provides publisher metadata, and related coverage to support discovery before sending readers to the original article.

Read original

At a glance

Publisher
ANMAT Noticias
Region
Argentina
Scope
Regulatory
Published
September 5, 2026

Publisher context, original article off-platform

This page presents the title, publisher metadata, and related coverage. The publisher did not provide a public summary in this feed. Full-text reading stays on the publisher's original site.

Source route

Continue on argentina.gob.ar

Leave the platform to read the original full article on the publisher site.

Source: ANMAT Noticias

Scope: Regulatory

Open original article
ANMAT emitió una Carta de Advertencia a UGAL FARMACÉUTICA S.A. por incumplimientos a las Buenas Prácticas de Fabricación | PharmaRadar360